Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, today announced the ...

AbbVie launched a revamped version of its Allē loyalty program, which ultimately was not adopted by providers. The marketing ...

German conservative leader Friedrich Merz pressed ahead with tough migration legislation backed by the far right, despite protests that have splintered the country just three weeks before a national ...

It is likely to see Friedrich Merz, a longstanding Thatcherite/Reaganite opponent of Angela Merkel within the federal republic’s centre-right CDU party, installed as chancellor. Merz’s strength of ...

Friedrich Merz, the frontrunner to become chancellor after Germany’s snap election next month, will take his campaign pitch to the World Economic Forum next week. The leader of the conservative ...

BERLIN — Germany's likely next chancellor, Friedrich Merz, has vowed to restore Germany’s industrial competitiveness by putting climate policies on the back burner. Germany’s economic policies have ...

Revance Therapeutics, Inc. faces financial struggles ... from Supernus Pharmaceuticals (SUPN), and Xeomin, from Merz Aesthetics — I concluded Revance may struggle to continue as a going concern ...

The bad news is that the bloom may be coming off the GLP-1 rose, which is presumably the reason why not only Eli Lilly but Novo Nordisk and Viking Therapeutics stock are suffering this morning.